2015 Fiscal Year Final Research Report
Expression of Inositol 1,4,5-trisphosphate receptors (InsP3Rs) in gastric cancer patients
| Project/Area Number |
25462041
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | University of Occupational and Environmental Health, Japan |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HIGURE Aiichiro 産業医科大学, 医学部, 非常勤医師 (20289581)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
MATAYOSHI Nobutaka 産業医科大学, 医学部, 非常勤医師 (00721630)
|
|---|
| Project Period (FY) |
2013-04-01 – 2016-03-31
|
| Keywords | IP3 レセプター / カルシウムシグナリング / 細胞増殖 / 胃癌 |
|---|
| Outline of Final Research Achievements |
The inositol 1,4,5-trisphosphate receptor (InsP3R) mediates Ca2+ signaling in epithelia and regulates cellular functions. Expression of all three InsP3R isoforms was evaluated in tissue from gastric mucosal and carcinomas surgically resected from 77 patients. Type 1 InsP3R was not seen in both normal gastric mucosa and gastric cancer. Dense apical localization of type 2 InsP3R was seen in gastric funds gland.Various level of type 2 InsP3R was observed in cancer cells. Dense apical localization of type 3 InsP3 receptor was seen in gastric pits. Various level of type 3 InsP3R was seen in gastric cancer. No correlation between type 3 InsP3 receptor expression and prognosis was observed in gastric cancer patients. Meanwhile, heavier expression of type 2 InsP3R also was associated with decreased 5-year survival. Type 2 InsP3R expression is a a novel and useful indicator of prognosis in patients with gastric cancer.
|
| Free Research Field |
消化器外科
|
